Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone

Radiotherapy and Oncology

Volumn 43, Issue 2, 1997, Pages 175-179

  Alberts, Albert S ^a   Smit, Ben J ^a   Louw, Werner K A ^b   Van Rensburg, Ado Janse ^a   Van Beek, Alet ^a   Kritzinger, Veronique ^a   Nel, Johan S ^a  

^a STEVE BIKO ACADEMIC HOSPITAL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

dose response; multiple doses; Samarium 153 EDTMP

Indexed keywords

ANTIEMETIC AGENT; CYTOSTATIC AGENT; HEMOGLOBIN; LEXIDRONAM SAMARIUM SM 153; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALGESIA; ARTICLE; BLOOD TOXICITY; BONE METASTASIS; BONE PAIN; BREAST CANCER; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL RATE;

BONE NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PALLIATIVE CARE; RADIOISOTOPES; RADIOTHERAPY DOSAGE; SAMARIUM;

EID: 0030949543     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)01912-9     Document Type: Article

References (7)

1. Collins, C., Early, J.P., Donaldson, G. et al. Samarium-153 EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J. Nucl Med. 1839-1844, 1993.
2. Eary, J.F., Collins, C., Stabin, M. et al. Samarium-153-EDTMP biodistribution and dosimetry estimation. J. Nucl. Med. 34: 1031-1036, 1993.
3. Farhangi, M., Holmes, R.A., Volkert, W.A., Logan, K.W. and Singh, A. Samarium-153-EDTMP: pharacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer. J. Nucl. Med. 33: 1451-1458, 1992.
4. Kaplan, E.L. and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481, 1958.
5. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50: 163-170, 1966.
6. Porter, A.T., McEwan, A.J.B., Pow, J.E. et al. Results of a randomized phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam radiation in the management of endocrine resistant metastatic prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 25: 805, 1993.
7. Turner, H.J. and Calringbold, P.G. A Phase II study of treatment of painful multivocal skeletal metastases with single and repeated dose Samarium-153-EDTMP. Eur. J Cancer. 27: 1084-1086, 1991.